Symbols

HQL

Abrdn Life Sciences Investors·NYSE

--(--)

7.83 / 10

Outperform

Analyst input is unavailable (ana_eval -1). Fund‑flow sentiment is strong, scoring 7.83/10 with overall inflow ratio above 0.5 and positive trends for small to large investors. Block and extra‑large flows are negative, but the net capital movement remains favorable.

Fund Flow Rating

What is the analyst consensus for HQL?

HQL holds a Neutral analyst rating, with 0% of experts assigning a Hold grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 7.83/10 (Outperform).